Myelodysplastic Syndrome Overview in the Elderly: Case Report

Authors

  • Devi Harmita Universitas Tanjungpura
  • Wulida Litaqia Tanjungpura University 1, Indonesia
  • Ainun Najib Febrya Rahman Tanjungpura University 1, Indonesia
  • Hanafi Tanjungpura University 1, Indonesia
  • Haryati Septiani Tanjungpura University 1, Indonesia
  • Dikki Saputra Universitas Tanjungpura

DOI:

https://doi.org/10.37680/jcd.v7i1.7056

Keywords:

Elderly, Hematological Disorders, Nursing Assessment of Myelodysplastic Syndrome

Abstract

Background: Myelodysplastic syndrome (MDS) is a hematopoietic disorder characterized by cytopenia, dysplasia, and genetic abnormalities that can transform into acute myeloid leukemia. MDS cases generally occur in children and adults. This case report involves a 75-year-old elderly individual with no history of MDS or family illness. Purpose of the Study: This study serves as a reference for screening the nursing perspective of MDS in the elderly. Methods: This research is a descriptive case report of 1 case. Results: A 75-year-old elderly patient with 1 month of weakness and pallor, blood pressure of 140/90 mmHg with controlled hypertension for 1 year. Laboratory results showed correlation with MDS symptoms: leukopenia (leukocytes 2.85 x 10^3/µl), thrombocytopenia (platelets 1,000/µl), and anemia (Hb 4.3g/dl). Conclusions: Hematological data support the patient experiencing MDS. Additionally, the patient's exposure to pesticides for 40 years also strongly supports the occurrence of MDS as it is a triggering factor for MDS.

References

Avagyan, S., & Shimamura, A. (2022). Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies. Frontiers in Oncology, 12(March). https://doi.org/10.3389/fonc.2022.813149

Avgerinou, C., Giannezi, I., Theodoropoulou, S., Lazaris, V., Kolliopoulou, G., Zikos, P., Alamanos, Y., Leotsinidis, M., & Symeonidis, A. (2017). Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece. Hematology, 22(7), 419–429. https://doi.org/10.1080/10245332.2016.1277006

Bestri Neli Agustin, Hanifah Maani, D. (2019). Gambaran Hematologi Pasien Myelodysplastic Syndrome di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas, 8(3), 500. https://doi.org/10.25077/jka.v8i3.1033

Bizymi, N., Pitsidianakis, G., Ierodiakonou, D., Stathakis, G., Vasarmidi, E., Hiraki, S., Bolaki, M., Karagiannis, K., Fanaridis, M., Liopyrakis, K., Marinos, L., Xilouri, I., Antoniou, K. M., & Tzanakis, N. (2021). Case Report: Diagnosis of Myelodysplastic Syndrome in a 72-Year-Old Female With Interstitial Lung Disease. Frontiers in Medicine, 8(August), 1–6. https://doi.org/10.3389/fmed.2021.673573

Brunner, A. M., Leitch, H. A., van de Loosdrecht, A. A., & Bonadies, N. (2022). Management of patients with lower-risk myelodysplastic syndromes. Blood Cancer Journal, 12(12), 1–13. https://doi.org/10.1038/s41408-022-00765-8

Crawford, J., Becker, P. S., Armitage, J. O., Blayney, D. W., Chavez, J., Curtin, P., Dinner, S., Fynan, T., Gojo, I., Griffiths, E. A., Hough, S., Kloth, D. D., Kuter, D. J., Lyman, G. H., Mably, M., Mukherjee, S., Patel, S., Perez, L. E., Poust, A., … Pluchino, L. (2017). Myeloid growth factors, version 2.2017. JNCCN Journal of the National Comprehensive Cancer Network, 15(12), 1520–1541. https://doi.org/10.6004/jnccn.2017.0175

Fenaux, P., Platzbecker, U., & Ades, L. (2020). How we manage adults with myelodysplastic syndrome. British journal of haematology, 189(6), 1016-1027.

Garcia-Manero, G., Chien, K. S., & Montalban-Bravo, G. (2020). Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management. American Journal of Hematology, 95(11), 1399–1420. https://doi.org/10.1002/ajh.25950

Hasserjian, R. P. (2018). Myelodysplastic Syndrome Updated. Pathobiology, 1–7. doi:10.1159/000489702

Lauritsen, T. B., Nørgaard, J. M., Dalton, S. O., Grønbæk, K., El-Galaly, T. C., & Østgård, L. S. G. (2023). 10-year nationwide trends in incidence, treatment patterns, and mortality of patients with myelodysplastic syndromes in Denmark. Leukemia Research, 128, 107056. https://doi.org/10.1016/j.leukres.2023.107056

Montoro, J., Gallur, L., Merchán, B., Molero, A., Roldán, E., Martínez-Valle, F., ... & Valcárcel, D. (2018). Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes. Annals of hematology, 97(8), 1349-1356.

Oktariani, S., Handaya, A. Y., & Purwanto, I. (2020). Peningkatan profil klinik-hematologi pada pasien sindrom mielodisplasia multilini paska splenektomi total. Jurnal Penyakit Dalam Udayana, 4(1), 1–4. https://doi.org/10.36216/jpd.v4i1.133

Platzbecker, U. (2019). Treatment of MDS. Blood, blood–2018–10844696. doi:10.1182/blood-2018-10-844696

SITORUS, V. L. M. (2018). Indeks-Indeks Trombosit Darah Tepi Dan Kejadian Myelodysplastic Syndrome. 69.

Wijaya, I. G. H. A. (2022). Myelodysplastic syndromes: Laporan Kasus. Intisari Sains Medis, 13(2), 613–617. https://doi.org/10.15562/ism.v13i2.1383

Downloads

Published

2025-04-30

How to Cite

Harmita, D., Wulida Litaqia, Ainun Najib Febrya Rahman, Hanafi, Haryati Septiani, & Dikki Saputra. (2025). Myelodysplastic Syndrome Overview in the Elderly: Case Report. Journal of Community Development and Disaster Management, 7(1), 403–413. https://doi.org/10.37680/jcd.v7i1.7056

Issue

Vol. 7 No. 1 (2025): Journal of Community Development and Disaster Management

Section

Articles

License

Copyright (c) 2025 Devi Harmita, Wulida Litaqia , Ainun Najib Febrya Rahman, Hanafi, Haryati Septiani

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

JCD: Journal of Community Development and Disaster Management rekomendasi pencipta untuk memegang hak cipta tanpa batasan dan batasan pencipta untuk memiliki hak publikasi tanpa batasan, juga pemilik hak komersial atas artikel tersebut adalah pencipta.